Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)
Titel:
Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)
Auteur:
Tomova, Antoaneta Bartsch, Rupert Brodowicz, Thomas Tzekova, Valentina Timcheva, Constanta Wiltschke, Christoph Gerges, Dany Abi Pawlega, Jan Spanik, Stanislav Inbar, Moshe Zielinski, Christoph C.